# Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

Study · id `cardio:ct-nct02298088` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02298088](<https://clinicaltrials.gov/study/NCT02298088>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02298088

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3799 participants.

## Technical summary

Registry record NCT02298088. Randomized; no masking; primary purpose treatment. Start 2015-08 (actual); primary completion 2017-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 3799 participants (enrolled count; ClinicalTrials.gov record NCT02298088, source copy `cardio:ctgov-nct02298088-2019-02-15`, retrieved 2026-10-26)
- Started: 2015-08 (actual) (ClinicalTrials.gov record NCT02298088, source copy `cardio:ctgov-nct02298088-2019-02-15`, retrieved 2026-10-26)
- Primary completion: 2017-12 (actual) (ClinicalTrials.gov record NCT02298088, source copy `cardio:ctgov-nct02298088-2019-02-15`, retrieved 2026-10-26)
- Completion: 2019-01 (actual) (ClinicalTrials.gov record NCT02298088, source copy `cardio:ctgov-nct02298088-2019-02-15`, retrieved 2026-10-26)
- Countries: Argentina; Australia; Brazil; Canada; China; Colombia; New Zealand; Peru; Russia; Ukraine (ClinicalTrials.gov record NCT02298088, source copy `cardio:ctgov-nct02298088-2019-02-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02298088-2019-02-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
- Acronym: TREAT
- Condition: Acute ST Segment Elevation Myocardial Infarction
- Condition: Thrombolysis in Myocardial Infarction Flow
- Intervention (Drug): Ticagrelor 180 mg
- Intervention (Drug): Clopidogrel
- Lead sponsor: Hospital do Coracao
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Hospital do Coracao (`cardio:org-hospital-do-coracao`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (`cardio:pubmed-29525822`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial (`cardio:pubmed-30898608`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial (`cardio:pubmed-35533724`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ad9571e2d6d55a9d25003d63640db5926fca6446abc332dca3e9b67e5204cc9f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
